These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 604778)

  • 21. Circulatory effects of fenfluramine in obese hypertensive patients.
    Mroczek WJ; Lee WR; Finnerty FA
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1197-202. PubMed ID: 4214654
    [No Abstract]   [Full Text] [Related]  

  • 22. Fenfluramine in the management of obesity.
    Datey KK; Kelkar PN; Pandya RS
    Br J Clin Pract; 1973 Oct; 27(10):373-5. PubMed ID: 4601613
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects and indications of fenfluramine in the treatment of obesity].
    Vignati E
    Vie Med Can Fr; 1973; 2(2):166-70. PubMed ID: 4706701
    [No Abstract]   [Full Text] [Related]  

  • 24. Fenfluramine and methylcellulose in the treatment of obesity: the relationship between plasma drug concentrations and therapeutic efficacy.
    Hossain M; Campbell DB
    Postgrad Med J; 1975; 51 Suppl 1(593):178-82. PubMed ID: 768965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the efficacy and acceptability of fenfluramine tablets (BP) and prolonged action capsules.
    Innes JA; Campbell IW; Millar J; Munro JF
    Postgrad Med J; 1975; 51 Suppl 1():160-2. PubMed ID: 768961
    [No Abstract]   [Full Text] [Related]  

  • 26. Double-blind cross-over study of fenfluramine (Ponderax) in obesity.
    Rastogi GK; Sharma PL; Saini GS; Kanen VL
    J Assoc Physicians India; 1972 Nov; 20(11):849-52. PubMed ID: 4570012
    [No Abstract]   [Full Text] [Related]  

  • 27. [Psychiatric complications in the treatment of obesity using fenfluramine].
    Klompenhouwer JL; Stricker BH; van Tilburg AJ; Moleman P; Pepplinkhuizen L
    Ned Tijdschr Geneeskd; 1988 Nov; 132(46):2114-7. PubMed ID: 3205320
    [No Abstract]   [Full Text] [Related]  

  • 28. Prolonged-action fenfluramine in non-diabetic patients with refractory obesity.
    Galloway DB; Logie AW; Petrie JC
    Postgrad Med J; 1975; 51 Suppl 1():155-7. PubMed ID: 768957
    [No Abstract]   [Full Text] [Related]  

  • 29. Relative unresponsiveness of obese diabetic compared to obese non-diabetic subjects to the weight-reducing effect of fenfluramine.
    Otim MA
    East Afr Med J; 1977 Feb; 54(2):91-5. PubMed ID: 885093
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparative trial of fenfluramine and diethylpropion inbesity.
    Silverstone JT; Cooper RM; Begg RR
    Br J Clin Pract; 1970 Oct; 24(10):423-5. PubMed ID: 4923926
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of obesity with fenfluramine (Ponderal) in general practice].
    Schiøttz-Christensen E
    Ugeskr Laeger; 1979 Sep; 141(39):2660-2. PubMed ID: 394442
    [No Abstract]   [Full Text] [Related]  

  • 32. Fenfluramine in the treatment of obesity.
    Spence AW; Medvei VC
    Br J Clin Pract; 1966 Dec; 20(12):643-4. PubMed ID: 5974503
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical study of the use of a "false food" associated with an anorectic drug in the treatment of exogenous obesity].
    Manieri C; Biffignandi P; Molinatti GM
    Minerva Dietol Gastroenterol; 1979; 25(2):201-7. PubMed ID: 471302
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of new formulation of fenfluramine in the management of the obese, diabetic African.
    Wilton D
    Postgrad Med J; 1975; 51 Suppl 1():138-9. PubMed ID: 1219673
    [No Abstract]   [Full Text] [Related]  

  • 35. Fenfluramine in the treatment of hypertensive patients with refractory obesity.
    Scott ME; Nelson PG
    Ulster Med J; 1975; 44(1):56-61. PubMed ID: 1124562
    [No Abstract]   [Full Text] [Related]  

  • 36. Anorectic effectiveness of differing dosage forms of fenfluramine.
    Tisdale SA; Ervin DK
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):589-94. PubMed ID: 819218
    [No Abstract]   [Full Text] [Related]  

  • 37. The variable response to fenfluramine in obesity.
    Preston PG; Ford MJ; Munro JF; Campbell DB
    Int J Obes; 1979; 3(4):359-61. PubMed ID: 528134
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic self-medication as a context for drug abuse research.
    Bigelow GE; Liebson I; Kaliszak J; Griffiths RR
    NIDA Res Monogr; 1978 Jul; (20):44-58. PubMed ID: 101860
    [No Abstract]   [Full Text] [Related]  

  • 39. A treatment for refractory obesity using fenfluramine without dietary restriction.
    Sedgwick JP
    Br J Clin Pract; 1970 Jun; 24(6):251-2. PubMed ID: 5456744
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients.
    Follows OJ
    Br J Clin Pract; 1971 May; 25(5):236-8. PubMed ID: 4931755
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.